Hepatitis C virus by hepatitis C (HCV) is caused by blood transfusion or blood products, blood dialysis and apheresis plasma transfusion was also ball, renal transplantation, intravenous drug use, sexual transmission, mother to child transmission of infectious caused. Hepatitis C is widely distributed more easily be turned into chronic, cirrhosis, and Hepatic carcinoma . Measures in the prevention of hepatitis C, screening donors is an important part of any anti-HCV-positive blood, or are not as HCVRNA positive donors.
Clinical manifestations: Mild gastrointestinal symptoms of acute hepatitis C, the ratio of the low occurrence of jaundice, ALT and serum bilirubin levels were significantly lower than that of acute hepatitis.
Check: Hepatitis C virus targets including anti-HCV and HCVRNA.
Treatment: Although acute hepatitis C can be healing in some patients, but all of acute hepatitis C patients should be given active treatment, because the acute stage well. The treatment of patients with specific conditions in accordance with proper rest, Jiang Mei, hepatoprotective, anti-virus and other symptomatic treatment, the most important treatment comes as anti-viral therapy.
The treatment of chronic hepatitis C, now widely recognized as valid only interferon, should also be early treatment. Combined clinical orientation. For example, interferon or interferon plus ribavirin plus thymosin film.
Disease described Viral hepatitis is a combination of viral hepatitis to liver damage to a group of systemic diseases. Classified according to etiology, there are currently identified hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E, by excluding the above-mentioned types of laboratory diagnosis of hepatitis was called non-A? Hepatitis. The recently discovered hepatitis G virus and transfusion transmitted virus causes hepatitis in dispute. Influenza A and Hepatitis E clinical manifestations similar to fatigue, loss of appetite, tired of the oil, liver, and abnormal liver function mainly in some cases jaundice. Influenza A and E and more manifestations of acute infection; B, C, D showed a chronic infection of most, a few cases can develop liver cirrhosis or hepatocellular carcinoma. The current lack effects on viral treatment. Influenza A and B vaccine-preventable, hepatitis C, type D there is no vaccine.
Disease causes Similar transmission of hepatitis B, but contains less HCV in body fluids, and for the RNA viruses, low resistance to the outside world, its mode of transmission of hepatitis B than the limitations of infectious weaker than that of hepatitis B virus. Transmitted primarily through parenteral.
(1) spread of blood transfusion and blood products: who is the main route of transmission, in the 20th century to the late 80's mid 90's, more than 70% of post-transfusion hepatitis is hepatitis. With improved screening methods, this mode of transmission has been clearly under control, anti-HCV-negative blood donors is not yet carrying HCV screening, blood transfusion is still the possibility of spread of hepatitis C, especially repeated blood transfusions, blood products are.
(2) injection, acupuncture, organ transplantation, hemodialysis Communication: China reports over 80% of intravenous drug users to anti-HCV positive. Hemodialysis and bone marrow transplantation Zhe Yi is at risk.
(3) living in close contact with infection: the distribution of HCV infection in approximately 40% of the no transfusion and blood products, injection history, known as community-acquired, most of which live in close contact by the spread.
(4) sexually transmitted: the existence of semen and saliva HCV, sexual contact can not be ignored. Multiple sexual partners, and homosexuals are at high risk.
(5) vertical transmission: mother to infant HCV infection, HCV infection risk of about 10%.
Clinical manifestations: Mild gastrointestinal symptoms of acute hepatitis C, the ratio of the low occurrence of jaundice, ALT and serum bilirubin levels were significantly lower than that of acute hepatitis.
Check: Hepatitis C virus targets including anti-HCV and HCVRNA.
Treatment: Although acute hepatitis C can be healing in some patients, but all of acute hepatitis C patients should be given active treatment, because the acute stage well. The treatment of patients with specific conditions in accordance with proper rest, Jiang Mei, hepatoprotective, anti-virus and other symptomatic treatment, the most important treatment comes as anti-viral therapy.
The treatment of chronic hepatitis C, now widely recognized as valid only interferon, should also be early treatment. Combined clinical orientation. For example, interferon or interferon plus ribavirin plus thymosin film.
Disease described Viral hepatitis is a combination of viral hepatitis to liver damage to a group of systemic diseases. Classified according to etiology, there are currently identified hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E, by excluding the above-mentioned types of laboratory diagnosis of hepatitis was called non-A? Hepatitis. The recently discovered hepatitis G virus and transfusion transmitted virus causes hepatitis in dispute. Influenza A and Hepatitis E clinical manifestations similar to fatigue, loss of appetite, tired of the oil, liver, and abnormal liver function mainly in some cases jaundice. Influenza A and E and more manifestations of acute infection; B, C, D showed a chronic infection of most, a few cases can develop liver cirrhosis or hepatocellular carcinoma. The current lack effects on viral treatment. Influenza A and B vaccine-preventable, hepatitis C, type D there is no vaccine.
Disease causes Similar transmission of hepatitis B, but contains less HCV in body fluids, and for the RNA viruses, low resistance to the outside world, its mode of transmission of hepatitis B than the limitations of infectious weaker than that of hepatitis B virus. Transmitted primarily through parenteral.
(1) spread of blood transfusion and blood products: who is the main route of transmission, in the 20th century to the late 80's mid 90's, more than 70% of post-transfusion hepatitis is hepatitis. With improved screening methods, this mode of transmission has been clearly under control, anti-HCV-negative blood donors is not yet carrying HCV screening, blood transfusion is still the possibility of spread of hepatitis C, especially repeated blood transfusions, blood products are.
(2) injection, acupuncture, organ transplantation, hemodialysis Communication: China reports over 80% of intravenous drug users to anti-HCV positive. Hemodialysis and bone marrow transplantation Zhe Yi is at risk.
(3) living in close contact with infection: the distribution of HCV infection in approximately 40% of the no transfusion and blood products, injection history, known as community-acquired, most of which live in close contact by the spread.
(4) sexually transmitted: the existence of semen and saliva HCV, sexual contact can not be ignored. Multiple sexual partners, and homosexuals are at high risk.
(5) vertical transmission: mother to infant HCV infection, HCV infection risk of about 10%.
Article Source: http://www.articlesbase.com/leadership-articles/basic-knowledge-of-hepatitis-c-2911439.html
